JEANETTE HEUERMANN: Open Payments
NPI 1528403029 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$199 in 9 payments from 6 companies in 2025. Trend: 2023 $271 · 2024 $187 · 2025 $199
Food & beverage: $199
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $52 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| Lilly USA, LLC | 2 | $40 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Astellas Pharma US Inc | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: VRAYLAR, LEQVIO, KISUNLA, Symbravo, Veozah, SHINGRIX.
Industry payments across MO — which companies pay providers there.
